tariquidar has been researched along with ribavirin in 2 studies
| Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (ribavirin) | Trials (ribavirin) | Recent Studies (post-2010) (ribavirin) |
|---|---|---|---|---|---|
| 210 | 16 | 138 | 12,316 | 1,880 | 5,443 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barraza, SJ; Blakely, PK; Dobry, CJ; Irani, DN; Keep, RF; Larsen, SD; Miller, DJ; Sindac, JA; Xiang, J | 1 |
| Grigoreva, TA; Novikova, DS; Sagaidak, AV; Tribulovich, VG; Vorona, SV | 1 |
2 other study(ies) available for tariquidar and ribavirin
| Article | Year |
|---|---|
Optimization of novel indole-2-carboxamide inhibitors of neurotropic alphavirus replication.
Topics: Animals; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Drug Design; Encephalitis Virus, Western Equine; Humans; Hydrophobic and Hydrophilic Interactions; Indoles; Mice; Molecular Weight; Solubility; Structure-Activity Relationship; Virus Replication | 2013 |
ATP Mimetic Attack on the Nucleotide-Binding Domain to Overcome ABC Transporter Mediated Chemoresistance.
Topics: | 2022 |